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TaiwanDear Editor,
Fluoroquinolones have been widely used to treat respira-
tory tract infections. Except for several cases or strains,
surveillance studies in Europe and the USA have indicated
that most Haemophilus influenzae isolates (> 99%) are
susceptible to fluoroquinolones.1,2 We describe the
increasing prevalence of fluoroquinolone resistance among
clinical isolates of Haemophilus species from the respira-
tory tract of patients in Southern Taiwan, and such finding
should be highlighted because we are losing one of the
antimicrobial weapons against bacterial pathogens that
cause respiratory tract infections.
According to the Clinical and Laboratory Standards
Institute, the in vitro susceptibility of moxifloxacin among
H. influenzae and Haemophilus parainfluenzae isolates has
been routinely tested using disk diffusion methods at two
medical centers in Southern Taiwan. The susceptibility of
ciprofloxacin in Haemophilus species has also been tested
since 2000 at Chi-Mei Hospital, Tainan, Taiwan. Between
2000 and 2015, the secular trend of ciprofloxacin suscep-
tibility among all non-repetitive H. influenzae isolates
decreased from 100% to 77% at CMH, and moxifloxacin
susceptibility decreased from 82% to 76% from 2007 to 2015
at National Cheng Kung University Hospital, Tainan, Taiwan
(Figure 1). Around the same period (2004e2015), the sus-
ceptibility of H. parainfluenzae to ciprofloxacin also
decreased rapidly at CMH from 93% to 36%, while the sus-
ceptibility of Streptococcus pneumoniae to moxifloxacin
saw no major change, remaining at 99% (data not shown).
Before 2004, surveillance studies from the North Amer-
ica, Latin America, and Europe reported that fluo-
roquinolone resistance accounted for only 0e0.3% of H.
influenzae isolates.1,2 A search for minimum inhibitory
concentration distributions in the database of the European
Committee on Antimicrobial Susceptibility Testing of 22,880
observations of H. influenzae from 12 data sources revealedPlease cite this article in press as: Chang C-M, et al., Increasing resist
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2 mg/mL, primarily 2e8 mg/mL.2 However, the percentage
of resistance among H. influenzae isolates was 2.6% be-
tween 2002 and 2004 in Japan.3 In 2007, 20 (42%) of 48 H.
influenzae isolates derived from surveillance cultures of
throat swabs and sputum at four nursing homes in Southern
Taiwan in 2007 were resistant to levofloxacin and 10 had a
levofloxacin MIC of > 32 mg/mL.4
A previous study reported that H. influenzae isolates
with reduced susceptibility to fluoroquinolones carried
amino acid changes at positions 84 and/or 88 in gyrA and/or
at the analogous positions (84, 88) in parC.3 Fluo-
roquinolone resistance in Gram-negative bacteria arose in a
multistep fashion with mutations in gyrA occurring as the
first step. However, in some Gram-positive bacteria such as
S. pneumoniae, parC subunit of topoisomerase IV is the
primary target of fluoroquinolones.5 The reason for
discrepancy of fluoroquinolone resistance among H. influ-
enzae, H. parainfluenzae, and S. pneumoniae isolates
during the past decade requires further study.
In 2004, a clonal outbreak of fluoroquinolone-resistant
H. influenzae spread in a long-term care facility in New
York, USA, and previous use of levofloxacin was associated
with the outbreak.5 Because of substantial incidence and
nonspecific presentation of bacterial infections, oral fluo-
roquinolones might be prescribed frequently for empirical
therapy of suspected infection events in older and multi-
comorbid residents. With increasing clinical prescriptions
of fluoroquinolones,6 the emergence and regional spread of
fluoroquinolone resistance in H. influenzae isolates might
eventually occur among institutionalized adults, particu-
larly debilitated elderly people. If this resistance trend
continues, it might threaten the therapeutic efficacy of
fluoroquinolones as empirical therapy for hospitalized
adults with respiratory tract infections. Our data show that
fluoroquinolones might no longer be safely assumed to beance to fluoroquinolones among Haemophilus species in Southern
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Figure 1. Secular trends of fluoroquinolone susceptibilities among Haemophilus isolates. CMH Z Chi-Mei Hospital; NCKUH Z
National Cheng Kung University Hospital.
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+ MODELan effective treatment for Haemophilus infections. Routine
susceptibility testing is essential, and continued surveil-
lance programs for antimicrobial resistance are warranted.
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